SUNITINIB SANDOZ

Capsule, hard, 50mg
RxActive license

Active substance (INN)

sunitinib

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength50mg
PackagingUkupno 28 kapsula tvrdih u blisteru (7x4) u kartonskoj kutiji
ManufacturerLek farmacevtska družba d.d. (Lek Pharmaceuticals d.d.), Slovenia
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX01)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateJanuary 31, 2022

Analogs in Montenegro

20

Other medicines with the same active substance

Source: CInMED register